US Patent Issued to The Regents of the University of California on April 7 for "Antiviral prodrugs, intermediate-and long-acting formulations and methods" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,292, issued on April 7, was assigned to The Regents of the University of California (Oakland, Calif.).

"Antiviral prodrugs, intermediate-and long-acting formulations and methods" was invented by Karl Y. Hostetler (Oakland, Calif.), James Beadle (Oakland, Calif.), Nadejda Valiaeva (Oakland, Calif.) and Robert T. Schooley (Oakland, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds and pharmaceutical formulations including a compound and an oil, which may be formulated for intermediate- or long-acting intramuscular injection. Methods for treating respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), coronavirus, SARS CoV-...